Swiss start-up Haya Therapeutics has formed a partnership with Eli Lilly – worth up to $1 billion – to look for new therapies for obesity in ... the 98% of human genetic material, sometimes ...

Tens of thousands of Americans will soon be forced by their health insurance to switch from one popular obesity drug to another ... published on Sunday in The New England Journal of Medicine.

WeightWatchers, known for its diet programs once endorsed by celebrities including Oprah Winfrey, has filed for bankruptcy after struggling to compete with new weight-loss drugs like Ozempic.

Taking a common infection-fighting medication as a toddler can raise the likelihood of obesity in later life, a new study has found. Researchers in Finland discovered children who took antibiotics ...

That kind of collaborative and inclusive approach should be what all doctors and nurses take when treating children struggling with obesity, say the authors of new Canadian clinical practice ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review ...